These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 26134028

  • 1. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells.
    Trabelsi MS, Daoudi M, Prawitt J, Ducastel S, Touche V, Sayin SI, Perino A, Brighton CA, Sebti Y, Kluza J, Briand O, Dehondt H, Vallez E, Dorchies E, Baud G, Spinelli V, Hennuyer N, Caron S, Bantubungi K, Caiazzo R, Reimann F, Marchetti P, Lefebvre P, Bäckhed F, Gribble FM, Schoonjans K, Pattou F, Tailleux A, Staels B, Lestavel S.
    Nat Commun; 2015 Jul 02; 6():7629. PubMed ID: 26134028
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery.
    Albaugh VL, Banan B, Antoun J, Xiong Y, Guo Y, Ping J, Alikhan M, Clements BA, Abumrad NN, Flynn CR.
    Gastroenterology; 2019 Mar 02; 156(4):1041-1051.e4. PubMed ID: 30445014
    [Abstract] [Full Text] [Related]

  • 4. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice.
    Potthoff MJ, Potts A, He T, Duarte JA, Taussig R, Mangelsdorf DJ, Kliewer SA, Burgess SC.
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb 15; 304(4):G371-80. PubMed ID: 23257920
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of active farnesoid X receptor on GLUTag enteroendocrine L cells.
    Niss K, Jakobsson ME, Westergaard D, Belling KG, Olsen JV, Brunak S.
    Mol Cell Endocrinol; 2020 Nov 01; 517():110923. PubMed ID: 32702472
    [Abstract] [Full Text] [Related]

  • 8. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P, Xie C, Nichols RG, Ferrell JM, Boehme S, Krausz KW, Patterson AD, Gonzalez FJ, Chiang JYL.
    Hepatology; 2018 Oct 01; 68(4):1574-1588. PubMed ID: 29486523
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pancreatic-derived factor impaired glucagon-like Peptide-1 production from GLUTag enterendorine L-cell line and intestines.
    Lai F, Chen Y, Lin H, Wang X, Zhu X, Li Y, Xiao H, Cao X.
    Mol Cell Endocrinol; 2017 Sep 05; 452():110-119. PubMed ID: 28549991
    [Abstract] [Full Text] [Related]

  • 15. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.
    Kumar DP, Asgharpour A, Mirshahi F, Park SH, Liu S, Imai Y, Nadler JL, Grider JR, Murthy KS, Sanyal AJ.
    J Biol Chem; 2016 Mar 25; 291(13):6626-40. PubMed ID: 26757816
    [Abstract] [Full Text] [Related]

  • 16. Red ginseng extracts ameliorate high-fat diet-induced obesity and insulin resistance by activating the intestinal TGR5-mediated bile acids signaling pathway.
    Li W, Zhuang T, Wang Z, Wang X, Liu L, Luo Y, Wang R, Li L, Huang W, Wang Z, Yang L, Ding L.
    Phytomedicine; 2023 Oct 25; 119():154982. PubMed ID: 37531904
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion.
    Yan S, Conley JM, Reilly AM, Stull ND, Abhyankar SD, Ericsson AC, Kono T, Molosh AI, Kubal CA, Evans-Molina C, Ren H.
    Cell Rep; 2022 Jan 04; 38(1):110179. PubMed ID: 34986353
    [Abstract] [Full Text] [Related]

  • 20. Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1.
    Shang Q, Saumoy M, Holst JJ, Salen G, Xu G.
    Am J Physiol Gastrointest Liver Physiol; 2010 Mar 04; 298(3):G419-24. PubMed ID: 20044510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.